Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director departure

Kezar Life Sciences, Inc. (KZR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "Investor Contact: Gitanjali Jain Vice President, Investor Relations and External Affairs"
08/17/2023 4 Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Gifted 3,500,000 shares @ $0
08/17/2023 SC 13D/A Morningside Venture Investments Ltd reports a 8.6% stake in Kezar Life Sciences, Inc.
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "Investor Contact:"
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 8-K Quarterly results
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 COOPER GRAHAM K (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 Garner Elizabeth (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 Kauffman Michael (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 Wallace Courtney (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 4 Klearman Micki (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/16/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "KEZAR LIFE SCIENCES, INC."
05/11/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Investor Contact:"
05/08/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/27/2023 8-K Quarterly results
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/17/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/14/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy